Skip to content
  • Sunday, 26 July 2026
  • 3:04 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Idvynso Secures FDA Approval, Charting a New Course in HIV Treatment While Biktarvy Maintains Market Dominance
Pharmaceutical R&D

Idvynso Secures FDA Approval, Charting a New Course in HIV Treatment While Biktarvy Maintains Market Dominance

Teuku Ryan Apr 23, 2026 0

MSD (Merck & Co) has achieved a significant milestone in the fight against Human Immunodeficiency Virus (HIV) with the U.S.…

Read More
Biotech & Genetic Research

Biotech Sector Thrives on Collaboration and Innovation, Charting Course for Future Discoveries at Major 2026 Scientific Gatherings

Jia Lissa Apr 9, 2026 0

The past two weeks have underscored a vibrant and increasingly collaborative biotech landscape, characterized by strategic partnerships aimed at addressing…

Read More
Biotech & Genetic Research

Leading Nanomedicine Experts Unveil Definitive Guide to Cancer Applications, Addressing Translational Hurdles and Charting Future Innovations

Jia Lissa Mar 14, 2026 0

Liverpool John Moores University (LJMU) Professor of Nanomedicine, Imran Saleem, and Qassim University Professor of Pharmaceutics, Ahmed AH Abdellatif, long-time…

Read More
Mars: Yeast’s Resilience Offers Clues to Extraterrestrial Life’s SurvivalEvolutionary Selection and Paternal Age How Aging Increases Disease-Causing Mutations in SpermDecentralizing Development: The Rise of Free, Offline AI Coding Assistants with OpenCode, Ollama, and Qwen3-CoderInsuring the trip: an underwriter on what it will take for approved psilocybin can become a real business
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ